TCTR20170410001Completed未知
The efficacy and safety of Erbium:YAG laser for treatment of enlarged pores: a pilot study
none0 sites19 target enrollmentStarted: April 10, 2017Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 19
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 25 Years to 60 Years (—)
- Sex
- All
Inclusion Criteria
- •patient with enlarged pores at nose and cheeks
Exclusion Criteria
- •-patient with photosensitivity, acne, infection or inflammation at the study area
- •-pregnancy and lactation
- •-using any product contain AHA or retinoic acid within 6 months prior to the study period
- •-treated with any laser or radiofrequency within 6 months prior to the study period
Investigators
Similar Trials
Recruiting
Not Applicable
Evaluation of Laser Snoring TreatmentSnoringObstructive Sleep ApneaC08.618RBR-5q2w7ztInstituto de Pesquisas Energéticas e Nucleares - IPE
Not yet recruiting
Phase 4
Effects of Er:YAG Laser for the De-Epithelialization of the Palatal GraftMiller Class I multiple gingival recessionsEr:YAG laserbilaminar techniquede-epithelializationgingival recessionTCTR20190418002Yeditepe University Faculty of Dentistry7
Recruiting
Not Applicable
Effect of laser in treatment of acne scarsAcne scar.IRCT20221031056355N1Tehran University of Medical Sciences20
Not yet recruiting
Not Applicable
Efficacy of Erbium YAG laser treatment in Overactive bladder syndrome: a randomized controlled trialPostmenopausal women who complain of urgency and frequency of urinationOveractive bladderPostmenopauseVaginal atrophyEr:YAGVaginal laser treatmentTreatmentBladder diaryMicturition diaryQuality of lifeMenopauseOABTCTR20181218002Ratchadapiseksompotch Fund118
Completed
Phase 4
Efficacy of fractional erbium laser-assisted tranexamic acid delivery in facial melasmaFacial melasmaFacialMelasmaTranexamic acidFractional ErbiumYAGLaserTCTR20210302002Sasima Eimpunth, MD33